Navigation Links
Anatomist Dr. Gunther von Hagens Clarifies: Plastinates Not For Sale
Date:2/5/2008

HEIDELBERG, Germany, Feb. 5 /PRNewswire/ -- During a lengthy interview with a reporter from a tabloid in Guben, Germany on Feb 4. 2008 anatomist, Dr. Gunther von Hagens explained his views on anatomy, the poor access to medical knowledge by lay people, and his own professional evolution from male nurse, to anesthesiologist, to Ivory Tower academic, to public scientist.

Dr. von Hagens believes that to differentiate between experts and laypersons points to an inherent bias that could lead to the colonizing of knowledge by the medical and scientific elite. Thus, he floated the idea that plastinates ought to be distributed to qualified individuals including laypersons. In a moment of scientific bravado on behalf of lay people, Dr. von Hagens claimed the enterprise as feasible and active, and went so far as to venture how such a plan would operate.

Dr. von Hagens regrets his statements on the matter and retracts them in their entirety. He apologizes to the body donors registered with the Institute for Plastination, who have entrusted their post-mortal bodies to the Institute for scientific study and the education of many. He reiterates that the body donors are the ethical backbone of BODY WORLDS. He thanks those who have participated in the BODY WORLDS exhibitions including donors, visitors, museums, exhibition sponsors, and the scientific and medical community for their understanding on this matter.


'/>"/>
SOURCE BODY WORLDS
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1

Related medicine news :

1. Rulings Send Lawsuits Against State Farm, American Family Back to Court, Hagens Berman Sobol Shapiro Announces
2. Hagens Berman Sobol Shapiro: Judge Orders Double Damages, Issues Stinging Rebuke in Average Wholesale Price Case
3. Hagens Berman Sobol Shapiro Announces Investigation Into Marketing of Vytorin and Zetia
4. CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... NEW YORK (May 22, 2012) -- Up to half of ... in a new "fusion" gene and formation of its unique ... promotes cancer growth. Now, Weill Cornell Medical College researchers have ... DNA, wrapped up in a little ball known as a ... has been thrown on thousands of genes, turning them on ...
(Date:5/22/2012)... to stray from her breeding partner and mate with ... that sleeping around can be costly. , The 20-year ... found that offspring conceived outside sparrows, social pairs ... offspring. The findings throw a monkey wrench into theories ... cheat. , Most bird species display some form of ...
(Date:5/22/2012)... Environmental Health Sciences (NIEHS), part of the National Institutes ... Program (SRP) at the University of California, San Diego. ... will fund continued research on the molecular and genetic ... other hazardous waste sites. , It is the third ... originally funded by the NIEHS in 2000. , ...
(Date:5/22/2012)... HealthDay Reporter , , MONDAY, May 21 (HealthDay News) ... unleash heated debate, a prominent U.S. government advisory ... no longer be screened for prostate cancer by ... The U.S. Preventive Services Task Force, an independent ... medicine, said PSA screening results in overdiagnosis of ...
(Date:5/22/2012)... TUESDAY, May 22 (HealthDay News) -- Hundreds of ... virus could develop potentially life-threatening liver complications over ... study. Researchers evaluated medical insurance claims data ... patients had advanced liver disease in 2008, and ... liver disease by 2015. The risk of ...
Breaking Medicine News(10 mins):Health News:Scientists unravel role of fusion gene in prostate cancer 2Health News:Scientists unravel role of fusion gene in prostate cancer 3Health News:Scientists unravel role of fusion gene in prostate cancer 4Health News:For monogamous sparrows, it doesn't pay to stray (but they do it anyway) 2Health News:UC San Diego Superfund Research Program receives $15 million grant renewal 2Health News:U.S. Advisers Say 'No' to Routine PSA Tests for Prostate Cancer 2Health News:U.S. Advisers Say 'No' to Routine PSA Tests for Prostate Cancer 3Health News:Hepatitis C Causing Liver Damage in Greater Numbers: Study 2
... in the wee small hours Friday with an all-night music ... onto the streets , while New York swung along for ... vibe changed from area to area. Thousands flocked to Abbesses ... streets as small-time artists enjoyed their 15 minutes of fame, ...
... importance as scientists believe it plays a key role in ... fevers diseases that infect over 50 million people ... of the Aedes aegypti mosquito which transmits deadly viral diseases ... the first of its kind on the newly-sequenced genome of ...
... Governments measures to address Indigenous child abuse, initially in the ... the AMA to play the key role in addressing this ... that the AMA is seeking a briefing from the Prime ... the proposals so work can commence as soon as practicable. ...
... said that all villages affected by chikungunya fever would ... awareness among people even as 17,000 suspected cases ... year. ,'We have asked the nine chikungunya-affected states ... Rural Health Mission, we will provide Rs.10,000 each to ...
... found that, apart from being heavy, overweight children share something ... 40 overweight children in Edmonton has revealed that each one ... found in intestinal cholesterol. ,The children presented high ... are characteristically high in overweight adults, remained in the normal ...
... Leire Garca Navarro, a researcher at the School of Pharmacy ... suffering colon and liver cancer. The new treatment has ... ,This discovery is the principal result of her ... in Cancer Cells of the Colon, which was subsidized by ...
Other Medicine News:Health News:France Celebrates Summer With All-night Music Fest; NY Swings Along 2Health News:Aedes Agypti Mosquitos Immune System Revealed 2Health News:Indigenous Child Abuse 2Health News:Chikungunya-hit Villages to Get Funds to Fight Mosquitoes 2Health News:Researchers Identify New Risk Marker for Obese Children 2Health News:Novel Treatment Beneficial for Colon and Liver Cancer 2
(Date:5/22/2012)... Calif., MAY 22, 2012 ThermoGenesis Corp. (NASDAQ: ... technologies for the processing, storage and administration of cell ... Thailand for its AXP® AutoXpress® Platform (AXP) used for ... expects to initiate commercial activities in the country later ... presence in the region,s cord blood market through our ...
(Date:5/22/2012)... Mass., May 22, 2012  Halo Therapeutics, ... therapeutics for rare fibrotic diseases, announced today ... $1.1 million from 12 not-for-profit foundations serving the ... the funds to expedite the phase 2 ... for Duchenne muscular dystrophy (DMD). HT-100, a ...
(Date:5/22/2012)... 22, 2012  Systech International, a leading provider ... protect product integrity and authenticity, today announced that ... Vice President. Mr. Harty will be ... of Systech,s Cloud Products and Solutions, and aligning ... "Mr. Harty has a unique perspective of ...
Breaking Medicine Technology:ThermoGenesis Announces Axp Approval In Thailand 2ThermoGenesis Announces Axp Approval In Thailand 3Halo Therapeutics Raises $1.1 Million to Expedite Phase 2 Study of HT-100 2Halo Therapeutics Raises $1.1 Million to Expedite Phase 2 Study of HT-100 3David F. Harty Joins Systech International as Vice President 2AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin 28AEZS 130 29 as First Oral Diagnostic Test for Growth Hormone Deficiency 14520 1AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin 28AEZS 130 29 as First Oral Diagnostic Test for Growth Hormone Deficiency 14520 2AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin 28AEZS 130 29 as First Oral Diagnostic Test for Growth Hormone Deficiency 14520 3China Medical Technologies Announces the SFDA Approval for its SPR System 14518 1China Medical Technologies Announces the SFDA Approval for its SPR System 14518 2China Medical Technologies Announces the SFDA Approval for its SPR System 14518 3Talecris Biotherapeutics Receives FDA Approval for PROLASTIN 28R 29 C 5548 1Talecris Biotherapeutics Receives FDA Approval for PROLASTIN 28R 29 C 5548 2Talecris Biotherapeutics Receives FDA Approval for PROLASTIN 28R 29 C 5548 3Talecris Biotherapeutics Receives FDA Approval for PROLASTIN 28R 29 C 5548 4Talecris Biotherapeutics Receives FDA Approval for PROLASTIN 28R 29 C 5548 5
... ATLANTA, March 24 After completing its review ... Data Safety,Monitoring Board (DSMB) has once again recommended ... collectively as the FAME(TM) (Fluocinolone,Acetonide in Diabetic Macular ... change. The trial is studying the use of ...
... treating pediatric acute lymphoblastic,leukemia combined with molecular science ... disease, MEMPHIS, Tenn., March 20 The ... for children with acute,lymphoblastic leukemia (ALL) will be ... research, according to an article,by St. Jude Children,s ...
Other Medicine Technology:DSMB Again Supports Continuation of the Phase III Clinical Trial of Medidur(TM) FA for the Treatment of DME 2DSMB Again Supports Continuation of the Phase III Clinical Trial of Medidur(TM) FA for the Treatment of DME 3Molecular Science Could Further Improve Leukemia Survival, Say St. Jude Researchers 2
... generation tissue valve from Medtronic, is the ... The Mosaic valve builds upon three decades ... excellent choice for patients who require aortic ... valve. For more than 20 years, Medtronics ...
Medtronic Aortic Punches are intended for use by cardiac surgeons during coronary artery bypass grafting procedures to create an opening in the wall of the vessel. All punches are sterile and disposa...
... treat heart rhythms that are abnormally fast ... often are used to treat sudden cardiac ... reduce the SCD mortality rate for these ... to less than 2 percent as verified ...
... new HF35-50 High Frequency Ultrasound system is ... high frequency system available. The HF35-50 allows ... of the anterior segment with 35MHz or ... ultrasound with a 20 MHz sealed B-probe. ...
Medicine Products: